Dai W - Search Results

1

Glucocorticoids and osteocyte autophagy.

Yao W, Dai W, Jiang JX, Lane NE. Yao W, et al. Among authors: dai w. Bone. 2013 Jun;54(2):279-84. doi: 10.1016/j.bone.2013.01.034. Epub 2013 Jan 26. Bone. 2013. PMID: 23356984 Free PMC article. Review.

2

Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.

Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE. Shahnazari M, et al. Among authors: dai w. Bone. 2010 May;46(5):1267-74. doi: 10.1016/j.bone.2009.11.019. Epub 2009 Nov 26. Bone. 2010. PMID: 19931661 Free PMC article.

3

Glucocorticoid dose determines osteocyte cell fate.

Jia J, Yao W, Guan M, Dai W, Shahnazari M, Kar R, Bonewald L, Jiang JX, Lane NE. Jia J, et al. Among authors: dai w. FASEB J. 2011 Oct;25(10):3366-76. doi: 10.1096/fj.11-182519. Epub 2011 Jun 24. FASEB J. 2011. PMID: 21705669 Free PMC article.

4

Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

Jia J, Yao W, Amugongo S, Shahnazari M, Dai W, Lay YA, Olvera D, Zimmermann EA, Ritchie RO, Li CS, Alliston T, Lane NE. Jia J, et al. Among authors: dai w. Bone. 2013 Jan;52(1):424-32. doi: 10.1016/j.bone.2012.10.017. Epub 2012 Oct 23. Bone. 2013. PMID: 23088940 Free PMC article.

5

Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

Amugongo SK, Yao W, Jia J, Dai W, Lay YA, Jiang L, Harvey D, Zimmermann EA, Schaible E, Dave N, Ritchie RO, Kimmel DB, Lane NE. Amugongo SK, et al. Among authors: dai w. Bone. 2014 Oct;67:257-68. doi: 10.1016/j.bone.2014.04.033. Epub 2014 Jul 10. Bone. 2014. PMID: 25016965 Free PMC article.

6

Prevention of glucocorticoid induced bone changes with beta-ecdysone.

Dai W, Jiang L, Lay YA, Chen H, Jin G, Zhang H, Kot A, Ritchie RO, Lane NE, Yao W. Dai W, et al. Bone. 2015 May;74:48-57. doi: 10.1016/j.bone.2015.01.001. Epub 2015 Jan 10. Bone. 2015. PMID: 25585248 Free PMC article.

7

Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, Guan M, Lane NE. Yao W, et al. Among authors: dai w. PLoS One. 2010 Jul 1;5(7):e11410. doi: 10.1371/journal.pone.0011410. PLoS One. 2010. PMID: 20625385 Free PMC article.

8

Reversing bone loss by directing mesenchymal stem cells to bone.

Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE. Yao W, et al. Among authors: dai w. Stem Cells. 2013 Sep;31(9):2003-14. doi: 10.1002/stem.1461. Stem Cells. 2013. PMID: 23818248 Free PMC article.

9

Beta-Ecdysone Protects Mouse Osteoblasts from Glucocorticoid-Induced Apoptosis In Vitro.

Dai WW, Wang LB, Jin GQ, Wu HJ, Zhang J, Wang CL, Wei YJ, Lee JH, Lay YE, Yao W. Dai WW, et al. Planta Med. 2017 Jul;83(11):888-894. doi: 10.1055/s-0043-107808. Epub 2017 Apr 7. Planta Med. 2017. PMID: 28388784

10

β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.

Dai W, Zhang H, Zhong ZA, Jiang L, Chen H, Lay YA, Kot A, Ritchie RO, Lane NE, Yao W. Dai W, et al. Clin Orthop Relat Res. 2015 Aug;473(8):2495-504. doi: 10.1007/s11999-015-4246-5. Clin Orthop Relat Res. 2015. PMID: 25822452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,617 results

Search Page